SCYNEXIS Inc SCYX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/17/24 EDT
2.77quote price arrow up+0.36 (+14.94%)
Volume
898,382
52 week range
1.35 - 3.87
Loading...
  • Open2.55
  • Day High2.90
  • Day Low2.46
  • Prev Close2.41
  • 52 Week High3.87
  • 52 Week High Date09/05/23
  • 52 Week Low1.35
  • 52 Week Low Date03/19/24

Key Stats

  • Market Cap104.65M
  • Shares Out37.78M
  • 10 Day Average Volume0.36M
  • Dividend-
  • Dividend Yield-
  • Beta1.54
  • YTD % Change24.22

KEY STATS

  • Open2.55
  • Day High2.90
  • Day Low2.46
  • Prev Close2.41
  • 52 Week High3.87
  • 52 Week High Date09/05/23
  • 52 Week Low1.35
  • 52 Week Low Date03/19/24
  • Market Cap104.65M
  • Shares Out37.78M
  • 10 Day Average Volume0.36M
  • Dividend-
  • Dividend Yield-
  • Beta1.54
  • YTD % Change24.22

RATIOS/PROFITABILITY

  • EPS (TTM)2.01
  • P/E (TTM)1.38
  • Fwd P/E (NTM)-8.27
  • EBITDA (TTM)74.272M
  • ROE (TTM)458.59%
  • Revenue (TTM)140.385M
  • Gross Margin (TTM)88.97%
  • Net Margin (TTM)72.18%
  • Debt To Equity (MRQ)16.72%

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On SCYNEXIS Inc

 

Profile

MORE
SCYNEXIS, Inc. is a biotechnology company. It is pioneering medicine to overcome and prevent difficult-to-treat and drug-resistant infections. It develops antifungal platform fungerps, a novel class of antifungal agents called triterpenoids, that are structurally distinct glucan synthase inhibitors and have generally shown in vitro and in vivo activity against a range of human fungal pathogens, such as Candida and Aspergillus genera, including multidrug-resistant strains, and...
Guy Macdonald
Non-Executive Independent Chairman of the Board
David Angulo M.D.
President, Chief Executive Officer, Director
Ivor Macleod CPA
Chief Financial Officer
Scott Sukenick J.D.
General Counsel
Address
1 Evertrust Plaza, 13Th Floor
Jersey City, NJ
07302-6548
United States

Top Peers

SYMBOLLASTCHG%CHG
ASRT
Assertio Holdings Inc
1.07+0.05+4.90%
ACORQ
Acorda Therapeutics Inc
0.605+0.095+18.6275%
AYTU
Aytu Biopharma Inc
2.94-0.02-0.68%
MEIP
MEI Pharma Inc
3.15+0.22+7.51%
ALIM
Alimera Sciences Inc
3.20-0.08-2.44%